Background When concurrent chemoradiotherapy (CCRT) is administered for limited-stage
small cell lung cancer (LS-SCLC), the early incorporation of thoracic radiotherapy (TRT) is …

Thoracic radiotherapy (TRT) is one of the main treatments in limited-stage small cell lung
cancer (LS-SCLC). Hyperfractionated TRT (45 Gy, 1.5 Gy twice daily) has been the standard …

Introduction For limited-stage small-cell lung cancer (LS-SCLC), National Comprehensive
Cancer Network guidelines recommend that thoracic radiotherapy (TRT) be delivered …

Concurrent chemoradiotherapy (CRT) has been recommended and applied widely as the
standard treatment for limited‐stage small cell lung cancer (LS‐SCLC). However …

The optimal protocol for thoracic radiotherapy (TRT) in combination with chemotherapy in
patients with limited-stage small-cell lung cancer (LS-SCLC) remains elusive. The present …

Purpose To replicate an earlier National Cancer Institute of Canada (NCIC) trial that
examined the effect on survival of the timing of thoracic radiotherapy (TRT) in patients with …

Background Chemotherapy (CT) combined with radiotherapy is the standard treatment of
'limited-stage'small-cell lung cancer. However, controversy persists over the optimal timing …

8512 Background: Concurrent chemotherapy and TRT is standard treatment of LS SCLC.
BID TRT of 45 Gy/30 fractions is the most recommended schedule. Trials report 5-year …

7004 Background: Concurrent thoracic radiotherapy (TRT) with chemotherapy has been
regarded as optimal treatment for limited-disease small cell lung cancer (SCLC). However …

Purpose We employed meta-analytic techniques to evaluate early (E) versus late (L) timing
of thoracic radiation therapy (RT) in limited-stage small-cell lung cancer (LS-SCLC). In …